[go: up one dir, main page]

BR9815016A - Utilização de uma mistura de um diol e um ácido alfa-hidroxi para o tratamento de doenças hiperceratóticas da pele - Google Patents

Utilização de uma mistura de um diol e um ácido alfa-hidroxi para o tratamento de doenças hiperceratóticas da pele

Info

Publication number
BR9815016A
BR9815016A BR9815016-2A BR9815016A BR9815016A BR 9815016 A BR9815016 A BR 9815016A BR 9815016 A BR9815016 A BR 9815016A BR 9815016 A BR9815016 A BR 9815016A
Authority
BR
Brazil
Prior art keywords
diol
alpha
mixture
skin
treatment
Prior art date
Application number
BR9815016-2A
Other languages
English (en)
Inventor
Agneta Ganemo
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Publication of BR9815016A publication Critical patent/BR9815016A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<B>UTILIZAçãO DE UMA MISTURA DE UM DIOL E UM áCIDO ALFA-HIDROXI PARA O TRATAMENTO DE DOENçAS HIPERCERATóTICAS DA PELE<D> é provida a utilização de composições contendo uma mistura de um diol e um ácido alfa-hidroxi em um veículo de semi-absorção para o tratamento tópico de doenças hiperceratóticas da pele.
BR9815016-2A 1997-11-25 1998-11-25 Utilização de uma mistura de um diol e um ácido alfa-hidroxi para o tratamento de doenças hiperceratóticas da pele BR9815016A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203681 1997-11-25
PCT/EP1998/007759 WO1999026617A1 (en) 1997-11-25 1998-11-25 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases

Publications (1)

Publication Number Publication Date
BR9815016A true BR9815016A (pt) 2000-10-03

Family

ID=8228970

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815016-2A BR9815016A (pt) 1997-11-25 1998-11-25 Utilização de uma mistura de um diol e um ácido alfa-hidroxi para o tratamento de doenças hiperceratóticas da pele

Country Status (21)

Country Link
US (1) US6399082B1 (pt)
EP (1) EP1032378B1 (pt)
CN (1) CN1140266C (pt)
AT (1) ATE213939T1 (pt)
AU (1) AU754420B2 (pt)
BG (1) BG64743B1 (pt)
BR (1) BR9815016A (pt)
CA (1) CA2310049C (pt)
CZ (1) CZ290165B6 (pt)
DE (1) DE69804130T2 (pt)
DK (1) DK1032378T3 (pt)
ES (1) ES2174533T3 (pt)
HU (1) HU226065B1 (pt)
IS (1) IS2147B (pt)
NO (1) NO320100B1 (pt)
NZ (1) NZ504458A (pt)
PL (1) PL190023B1 (pt)
PT (1) PT1032378E (pt)
SK (1) SK284505B6 (pt)
TR (1) TR200001486T2 (pt)
WO (1) WO1999026617A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5778367A (en) * 1995-12-14 1998-07-07 Network Engineering Software, Inc. Automated on-line information service and directory, particularly for the world wide web
CA2329252A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals Inc. Compositions and methods for topical delivery of oligonucleotides
US6410036B1 (en) * 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
WO2002096374A2 (en) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
EP1996021B1 (en) 2006-02-28 2017-12-13 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
BRPI0909374A2 (pt) * 2008-03-25 2015-10-06 Paloma Pharmaceuticals Inc métodos para tratar desordens fibróticas
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US8895542B2 (en) * 2009-04-13 2014-11-25 Vanangamudi Subramaniam Sulur Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
WO2010127411A1 (en) * 2009-05-08 2010-11-11 Allmedic Pty Ltd Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
CN107308163A (zh) * 2010-11-04 2017-11-03 442合资有限责任公司 用于治疗皮肤病的组合物和方法
US9381187B2 (en) 2011-02-16 2016-07-05 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
AU7656894A (en) * 1993-09-15 1995-04-03 Unilever Plc Skin care method and composition

Also Published As

Publication number Publication date
NO20002649L (no) 2000-07-24
SK284505B6 (sk) 2005-05-05
ES2174533T3 (es) 2002-11-01
HU226065B1 (hu) 2008-04-28
CA2310049A1 (en) 1999-06-03
US6399082B1 (en) 2002-06-04
IS5505A (is) 2000-05-23
HK1034194A1 (en) 2001-10-19
TR200001486T2 (tr) 2001-07-23
IS2147B (is) 2006-09-15
AU1965999A (en) 1999-06-15
HUP0100066A3 (en) 2006-07-28
BG104470A (en) 2001-03-30
CN1280495A (zh) 2001-01-17
WO1999026617A1 (en) 1999-06-03
CN1140266C (zh) 2004-03-03
HUP0100066A2 (hu) 2001-08-28
EP1032378A1 (en) 2000-09-06
PL340679A1 (en) 2001-02-12
DE69804130T2 (de) 2002-07-25
SK7432000A3 (en) 2001-05-10
NO320100B1 (no) 2005-10-24
ATE213939T1 (de) 2002-03-15
NZ504458A (en) 2002-03-01
AU754420B2 (en) 2002-11-14
NO20002649D0 (no) 2000-05-24
DE69804130D1 (de) 2002-04-11
BG64743B1 (bg) 2006-02-28
CZ290165B6 (cs) 2002-06-12
PT1032378E (pt) 2002-07-31
EP1032378B1 (en) 2002-03-06
PL190023B1 (pl) 2005-10-31
DK1032378T3 (da) 2002-04-15
CA2310049C (en) 2008-02-19
CZ20001920A3 (cs) 2001-04-11

Similar Documents

Publication Publication Date Title
BR9815016A (pt) Utilização de uma mistura de um diol e um ácido alfa-hidroxi para o tratamento de doenças hiperceratóticas da pele
BR9713287A (pt) Composições de esfingomielinase e seu uso
MX9703694A (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
ID21761A (id) Komposisi perawatan kulit yang mengandung asam dan retinoid
BR9914925A (pt) Processos para reduzir o crescimento de cabelo de mamìfero, para tratar uma área de pele, e, para produzir uma composição para inibir crescimento do cabelo de mamìfero, uso de um inibidor de fosfatase alcalina, e, composição usada para inibir crescimento de cabelo de mamìfero.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
MY132705A (en) Novel compounds with analgesic effect
BR0112142A (pt) Composição para cuidado com a pele e métodos cosméticos de condicionar a pele e de reproduzir o efeito sobre a pele de ácido retinóico
ES2141208T3 (es) Utilizacion de una cantidad eficaz de sustancias activas para el tratamiento de pieles mixtas.
AU7023987A (en) Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
BR9810307A (pt) Composição cosmética.
BR9509006A (pt) Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
EA199700380A1 (ru) Бициклические ароматические соединения, фармацевтическая и косметическая композиции на их основе и применение косметической композиции
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
DE69842133D1 (de) Zusammensetzungen und Kits zur Erhöhung der Abgabe von therapeutischen Mitteln an Zellen
IS2257B (is) Samsetning með aselínsýru
BR9709154A (pt) Utilização de um inibidor da atividade do ácido retinóico em uma composição cosmética ou para a preparação de uma composição farmacêutica
ATE173608T1 (de) Präparat gegen haarausfall und brüchiche nägel
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
BR9807157A (pt) Composto, composição, utilização de um composto e processo de tratamento cosmético dos sinais do envelhecimento cutâneo
DK0951294T3 (da) Sårhelende formuleringer indeholdende humanplasmafibronectin
DE69815277D1 (de) Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/191, A61K 31/47, A61K 9/06, A61K 47/06, A61P 17/12

Ipc: A61K 31/191 (2007.10), A61K 31/47 (2007.10), A61K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO UMA VEZ QUE O MESMO NAO ATENDE O DISPOSTO NOS ARTIGOS 8O E 13 DA LEI 9279/96.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: ASTELLAS PHARMA EUROPE B.V. (NL)

Free format text: NOME ALTERADO DE: YAMANOUCHI EUROPE B.V.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]